Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- NBI to Reach Mid-term Goal with Int'l Strategic Products
July 8, 2002
- Zeria, Yamanouchi Agree to Develop, Market Gastroprokinetic Z-338
July 8, 2002
- GL for Low Back Pain Compiled
July 8, 2002
- Sankyo, Kirin to Comarket Espo by March 2005
July 8, 2002
- Vardenafil Improves ED in 73% of Diabetics
July 8, 2002
- VITAL-NET Acquires Ohmori Yakuhin Tohoku
July 8, 2002
- Terumo's New Liposome Containing Anticancer Agent Effective
July 8, 2002
- Listed Drug Manufacturers' Combined Sales Up 4.9% to \6,043.6 Bil.
July 8, 2002
- Dr Ueda Calls For Increase in CRC and Enhanced Functions of IRB
July 8, 2002
- Otsuka: Consolidated Sales Up 2% to \489.9 Bil.
July 8, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
July 8, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
July 8, 2002
- Ain Pharmaciez: Sales Up 26.1% to \24.7 Bil.
July 8, 2002
- Korosho to Finalize Drug Industry Vision by Summer
July 1, 2002
- Functional Food Foundation Set Up
July 1, 2002
- Less than Half of Companies Have PAL Compliance System
July 1, 2002
- OTC NEWS IN BRIEF
July 1, 2002
- Clinical Efficacy Is More Important in Selecting Comparator Drugs: Dr Yazaki of DPO
July 1, 2002
- WORLD NEWS IN BRIEF
July 1, 2002
- FPMAJ Proposes Concrete Application Rule for New NHI Pricing Method
July 1, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…